Amitabh, Abhishek Bachchan stable, don't require aggressive treatment: Hospital

Simran Kashyap

Mumbai, July 13: Megastar Amitabh Bachchan and his son, actor Abhishek Bachchan, who were admitted to a hospital here after testing positive for coronavirus, are "clinically stable", hospital sources said on Monday.

Amitabh, 77, and Abhishek, 44, revealed their diagnosis on Twitter on July 11, saying they were in the isolation ward of Nanavati Hospital.

"They both are in the (isolation) ward and are clinically stable. At present, they do not requiring aggressive treatment. They are okay with the first line of medication. They are being given supportive therapy," a hospital insider told PTI.

"Their vitals and appetite are fine," the source added.

On Sunday, Amitabh's daughter-in-law, actor Aishwarya, 46, and her eight-year-old daughter Aaradhya also tested positive for COVID-19. Abhishek confirmed Aishwarya and Aaradhya's diagnosis on the microblogging site on Sunday, adding that they will be "self-quarantining at home". The actor said he and his father will "remain in hospital till the doctors decide otherwise".

Taking to his blog on Sunday, Amitabh thanked his admirers for their prayers and concern for him and his family members. "My dearest extended family, your concern, your prayers and your wishes for Abhishek, Aishwarya, Aaradhya and me for a speedy recovery has filled me with unending gratitude. I thank you all," the screen icon wrote.

With 1,263 new COVID-19 cases being recorded on Sunday, Mumbai's case count has mounted to 92,720, the Brihanmumbai Municipal Corporation (BMC) said.

Also Read:

Amitabh Bachchan expresses 'unending gratitude' to fans after COVID-19 diagnosis

Abhishek confirms Aishwarya, Aaradhya's COVID-19 diagnosis, says they will quarantine at home

Aishwarya Rai Bachchan & her daughter test positive for Coronavirus

Our goal is to create a safe and engaging place for users to connect over interests and passions. In order to improve our community experience, we are temporarily suspending article commenting.